Literature DB >> 6655236

The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved method.

D J Hnatowich, R L Childs, D Lanteigne, A Najafi.   

Abstract

Isotopes of iodine are often employed as radiolabels for antibodies used in radioimmunodetection studies in which tumor localization is determined by external imaging. Because of drawbacks associated with the use of these isotopes, alternative labeling methods have been considered; such as covalently attaching strong chelators so that the coupled protein may be radiolabeled with metallic radionuclides by chelation. We have developed a method of coupling the strong chelator diethylenetriaminepentaacetic acid (DTPA) which is simple, efficient, and superior to reported methods. Using the cyclic anhydride, coupling to IgG antibody is about 75% efficient and is completed in less than 1 min at neutral pH. Because the concentration of hydrolytic products is small, the coupled protein is rapidly purified for use or storage. Labeling of the protein is also accomplished rapidly and the labeled product has been shown to be stable both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6655236     DOI: 10.1016/0022-1759(83)90311-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  38 in total

1.  Carbohydrate-derivatized immunoconjugate of the anti-(carcinoembryonic antigen) monoclonal antibody C46: immunohistological reactivity and pharmacokinetic comparison with a randomly derivatized C46 immunoconjugate.

Authors:  M J Rosenstraus; W L Davis; A D Lopes; C J D'Aleo; S C Gilman
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Effect of isoelectric point on biodistribution and inflammation: imaging with indium-111-labelled IgG.

Authors:  C I ten Kate; A J Fischman; R H Rubin; A J Fucello; D Riexinger; R A Wilkinson; L Du; B A Khaw; H W Strauss
Journal:  Eur J Nucl Med       Date:  1990

3.  Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinoma.

Authors:  Gui-Ping Li; Hui Zhang; Cheng-Mo Zhu; Jian Zhang; Xu-Feng Jiang
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

4.  Radiolabelling of monoclonal antibodies: optimization of conjugation of DTPA to F(ab')2-fragments and a novel measurement of the degree of conjugation using Eu(III)-labelling.

Authors:  M Hartikka; P Vihko; M Södervall; L Hakalahti; P Torniainen; R Vihko
Journal:  Eur J Nucl Med       Date:  1989

5.  Scintigraphic imaging of P-glycoprotein expression with a radiolabelled antibody.

Authors:  Julliëtte E M van Eerd; Lioe-Fee de Geus-Oei; Wim J G Oyen; Frans H M Corstens; Otto C Boerman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-11       Impact factor: 9.236

6.  Polyclonal 111In-IgG, 125I-LDL and 125I-endothelin-1 accumulation in experimental arterial wall injury.

Authors:  L Prat; G Torres; I Carrió; M Roca; V Riambau; L Berná; M Estorch; I Ferrer; C García
Journal:  Eur J Nucl Med       Date:  1993-12

7.  A preliminary pharmacokinetic study of 111In-labeled 260F9 anti-(breast cancer) antibody in patients.

Authors:  T W Griffin; F Bokhari; J Collins; M Stochl; M Bernier; M Gionet; D Siebecker; M Wertheimer; E S Giroves; L Greenfield
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

8.  Labeling of monoclonal antibodies with a 67Ga-phenolic aminocarboxylic acid chelate. Part I. Chemistry and labeling technique.

Authors:  J Schuhmacher; R Matys; H Hauser; W Maier-Borst; S Matzku
Journal:  Eur J Nucl Med       Date:  1986

9.  Inhibition of the hepatocyte uptake of radiolabelled monoclonal antibodies by chelating agents.

Authors:  B R Davidson; P B Boulos; J B Porter
Journal:  Eur J Nucl Med       Date:  1990

10.  Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides.

Authors:  Erik Vegt; Annemarie Eek; Wim J G Oyen; Marion de Jong; Martin Gotthardt; Otto C Boerman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-01       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.